Free Trial
NASDAQ:YMT

Yimutian (YMT) Stock Price, News & Analysis

Yimutian logo
$0.14 -0.01 (-5.44%)
As of 03:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Yimutian Stock (NASDAQ:YMT)

Advanced

Key Stats

Today's Range
$0.14
$0.16
50-Day Range
$0.14
$0.64
52-Week Range
$0.13
$6.05
Volume
1.37 million shs
Average Volume
3.94 million shs
Market Capitalization
$15.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Receive YMT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yimutian and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

YMT Stock News Headlines

Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
Yimutian Inc ADR (YMT)
See More Headlines

YMT Stock Analysis - Frequently Asked Questions

Yimutian's stock was trading at $1.58 on January 1st, 2026. Since then, YMT shares have decreased by 91.2% and is now trading at $0.1390.

Yimutian shares reverse split on Monday, May 18th 2026.The 1-15 reverse split was announced on Wednesday, April 29th 2026. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, May 15th 2026. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Yimutian (YMT) raised $23 million in an initial public offering (IPO) on Tuesday, August 19th 2025. The company issued 5,010,000 shares at a price of $4.10-$5.00 per share.

Shares of YMT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Services
Industry
Services – Computer Processing, Data Preparation And Processing
Sub-Industry
Business Services
Current Symbol
NASDAQ:YMT
Previous Symbol
NASDAQ:YMT
CIK
1991605
Web
N/A
Fax
N/A
Employees
573
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$146.88 million
Price / Sales
0.11
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
114,377,000
Free Float
N/A
Market Cap
$15.90 million
Optionable
N/A
Beta
N/A
10 Best Stocks to Own in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:YMT) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners